Accellix Announces Board of Directors Appointment

Accellix announces the appointment of a new Board Member, Charles (Chuck) Piazza.

Piazza has over 35 years of global experience within the life science industry serving the pharmaceutical, biotechnology and medical research sectors. His recent positions included Vice President and General Manager for the Molecular Biology Research products division of Life Technologies (now part of Thermo Fisher) and Vice President for Global Sales Operations and Pricing.

"In the pursuit of new and efficacious therapies, one must adhere to the strictest set of analytical methods," Piazza said. "Cells that are undergoing different processes that turn them into potential therapeutic tools, need to be tested swiftly and reproducibly. That’s what attracted me to the Accellix mission. I intend to help Accellix’s management pursue this mission and am confident we will succeed in doing so."

"I have known Chuck for more than a decade and have seen him lead and grow businesses in the life science tools industry," Nir Nimrodi, Accellix’s Executive Chairman said. "He did it with intelligence, intense focus and unwavering relentlessness. I had the privilege to professionally benefit from working with him and am looking forward to his contributions to our company and team."

Prior to joining Life Technologies (ThermoFisher), Piazza was Vice President and General Manager for molecular biology tools at Cambrex BioSciences (now part of Lonza), a supplier of molecular biology and cell culture products, including normal human and hematopoietic stem cells. Earlier in his career, Piazza also served as the Director of Sales and Marketing at FMC BioProducts, a life science reagents division of FMC Corporation.

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com